Rhythm Pharmaceuticals
A Director of Nonclinical Development at Rhythm leads scientific strategies for nonclinical development across multiple programs, from IND-enabling to late clinical development. The role involves overseeing toxicology, DMPK, and ADME studies, managing CRO relationships, and contributing to regulatory documents.
Headquarters
Boston, Massachusetts, United States
Company Size
51-200 employees
Founded
2008
Rhythm Pharmaceuticals is a global biopharmaceutical company dedicated to transforming the lives of patients with rare neuroendocrine diseases by developing precision medicines that address the root cause. Its lead program, setmelanotide, targets the MC4R pathway to treat certain rare genetic forms of severe obesity and related neuroendocrine disorders. Rhythm advances therapies through clinical development and commercialization while partnering with clinicians, payers, and patient communities to expand access and support long‑term care.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Rhythm Pharmaceuticals.
9% above the average for this role
Director/Senior Director, Nonclinical Safety
Nimbus Therapeutics
Nonclinical Safety Lead
BioLife Plasma Services
Associate Director, Regulatory Affairs – Nonclinical Development
Altasciences
Vice President of Nonclinical Drug Safety and Toxicology
Remix Therapeutics
Senior Director, Toxicology
Scripps Research
Senior Director, Toxicology
Latigobio